Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
摘要:
In our continuing efforts to identify small molecule vitronectin receptor antagonists, we have discovered a series of phenylbutyrate derivatives, exemplified by 16, which have good potency and excellent oral bioavailability (approximately 100% in rats). This new series is derived conceptually from opening of the seven-membered ring of SB-265123. (C) 2003 Elsevier Science Ltd. All rights reserved.
Compounds of the formula (1) are disclosed which are vitronectin receptor antagonists and are useful in the treatment of osteoporosis:
1
公式(1)的化合物被披露为抗血浆粘附素受体的拮抗剂,并且在骨质疏松症的治疗中有用:1
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
作者:William H Miller、Peter J Manley、Russell D Cousins、Karl F Erhard、Dirk A Heerding、Chet Kwon、Stephen T Ross、James M Samanen、Dennis T Takata、Irene N Uzinskas、Catherine C.K Yuan、R.Curtis Haltiwanger、Catherine J Gress、Michael W Lark、Shing-Mei Hwang、Ian E James、David J Rieman、Robert N Willette、Tian-Li Yue、Leonard M Azzarano、Kevin L Salyers、Brian R Smith、Keith W Ward、Kyung O Johanson、William F Huffman
DOI:10.1016/s0960-894x(03)00102-1
日期:2003.4
In our continuing efforts to identify small molecule vitronectin receptor antagonists, we have discovered a series of phenylbutyrate derivatives, exemplified by 16, which have good potency and excellent oral bioavailability (approximately 100% in rats). This new series is derived conceptually from opening of the seven-membered ring of SB-265123. (C) 2003 Elsevier Science Ltd. All rights reserved.